Atlas FDA

UROLOGIX TARGIS SYSTEM

FDA premarket approval P970008/S030 · decided 2006-03-20

Approval details

PMA number
P970008
Supplement
S030
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
UROLOGIX TARGIS SYSTEM
Generic name
System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy
Applicant
Urologix, LLC
Date received
2005-11-21
Decision date
2006-03-20
Days to decision
119 days
Decision code
APPR
Product code
MEQ
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Plymouth, MN
Statement
APPROVAL FOR UPGRADES TO THE TARGIS SYSTEM. THESE CHANGES INCLUDE IMPROVED APPEARANCE (WHICH REQUIRED REPLACING THE CONTROL UNIT EXTERIOR PANELS AND MOVING THE USER CONTROLS), IMPROVED ELECTROMAGNETIC COMPATIBILITY (EMC), AND OTHER COMPONENT AND MANUFACTURING MODIFICATIONS DUE TO COMPONENT OBSOLESCENCE.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.